Interference of M-protein on prothrombin time test - case report

Sandra Margetić1, Ivana Ćelap1, Lora Dukić1

  • 1Clinical Institute of Chemistry, Medical School University Hospital Sestre milosrdnice, Zagreb, Croatia.

Biochemia Medica
|June 28, 2016
PubMed

Insights

Monoclonal gammopathy can interfere with laboratory coagulation tests, specifically prothrombin time (PT) and thrombin time (TT). This case highlights how abnormal PT results led to the diagnosis of monoclonal gammopathy in an elderly patient.

Area of Science:

  • Clinical Chemistry
  • Hematology
  • Immunology

Background:

  • Routine coagulation testing is crucial for assessing hemostasis and diagnosing bleeding disorders.
  • Monoclonal gammopathy, characterized by the overproduction of a single type of immunoglobulin, can manifest with various clinical complications.

Observation:

  • An 88-year-old male presented with unmeasurable prothrombin time (PT) and normal activated partial thromboplastin time (aPTT) during routine testing.
  • Subsequent tests revealed persistently unmeasurable PT, prolonged thrombin time (TT), and a visible gelatinous precipitate in refrigerated plasma samples.
  • Laboratory findings indicated the presence of monoclonal protein (M-protein), specifically IgG lambda, suggesting monoclonal gammopathy.

Findings:

  • The patient's unmeasurable PT results were corrected to 67% activity in a mixing test with normal plasma, indicating in vitro interference.
  • Prolonged TT results suggested that the M-protein impacted fibrin polymerization, affecting this global coagulation assay.
  • Coagulation factor activities (II, V, VII, X) were within normal or elevated ranges, ruling out factor deficiencies as the cause of PT abnormalities.

Implications:

  • This case underscores the importance of recognizing M-protein interference in coagulation assays, particularly PT and TT.
  • Abnormal coagulation test results in the presence of M-protein warrant further investigation to differentiate between in vitro interference and true hemostatic abnormalities.
  • Accurate diagnosis of monoclonal gammopathy is essential for appropriate patient management and monitoring.

Related Concept Videos

Factors Affecting Protein-Drug Binding: Drug Interactions01:23

Factors Affecting Protein-Drug Binding: Drug Interactions

Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
693
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.3K
Inductively Coupled Plasma-Mass Spectrometry (ICP-MS): Interferences01:20

Inductively Coupled Plasma-Mass Spectrometry (ICP-MS): Interferences

Inductively coupled plasma–mass spectrometry (ICP–MS) is a highly selective and sensitive technique for accurate elemental analysis. Though the analysis of ICP–MS mass spectra is comparatively straightforward, it is affected by spectroscopic and non-spectroscopic interferences. Spectroscopic interferences arise when the plasma contains ionic species with an m/z value the same as the analyte ion. Spectroscopic interference can be categorized as isobaric, polyatomic ions, and...
1.6K